Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

Cannabidiol suppositories for sexual pain

Official title: The Use of Cannabidiol Suppositories for Sexual Pain: A Randomised Controlled Study

Run by London Metropolitan University · NCT07271030 · Data updated 2026-11-12

This project will test whether cannabidiol suppositories can reduce sexual pain and improve sexual function and well-being for adults who experience pain during intercourse or masturbation.

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment50 (estimated)
SponsorLondon Metropolitan University
Academic / other
Locations1 site (London)
StatusRecruiting
StartedJanuary 16, 2026
Main results expectedJuly 2027
Study endsDecember 2027
Registry record updatedAugust 25, 2026
Trial IDNCT07271030 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 or older who are currently experiencing sexual pain, have previously used cannabidiol without allergic reaction, have tried intercourse in the past month, and screen in the mild range on PHQ-9 and GAD-7.

Probably not a fit

People with a history of allergic reaction to cannabidiol, moderate-to-severe depression or anxiety, co-occurring clinical difficulties, those under 18, or those not sexually active recently are unlikely to be eligible or benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults who report sexual pain are randomized to one of four groups: three cannabidiol suppository dose groups (about 30 mg, 50 mg, and 100 mg) or a care-as-usual control. The suppository intervention is used over one month with a planned follow-up visit at 12 weeks to measure pain, sexual function, quality of life, and well-being. The trial combines quantitative outcomes with qualitative feedback gathered via approximately eight open-ended questions. Participants must have prior cannabidiol use without allergy and meet mild screening thresholds for depression and anxiety to minimize confounding comorbidities.

Why it matters

Potential benefit: If successful, this could provide a non-intoxicating, locally delivered option to lessen sexual pain and improve sexual function, quality of life, and overall well-being.

How similar studies have gone: Two small prior studies of cannabidiol suppositories have suggested pain-relieving effects for sexual pain, but the evidence remains limited and preliminary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Has previously used cannabidiol in any capacity and has not experienced any allergic reaction
* Is experiencing sexual pain
* There will be an absence of co occurring difficulties
* Has attempted sexual intercourse in the last month
* Age 18 years or older
* Read and write English
* Patient Health Questionnaire 9 screening score range between 0-9 mild
* General Anxiety Disorder 7 screening score range between 0-9 mild
* There are no restrictions on sex, gender, sexuality, or disability

Exclusion Criteria:

Has experienced an allergic reaction to cannabidiol in any capacity

* Has not attempted sexual intercourse in the last month
* Has co occurring difficulties
* Aged below 18 years old
* Are not experiencing sexual pain
* Patient Health Questionnaire 9 screening score range between moderate to severe - 10-27
* General Anxiety Disorder 7 screening score range between 10- 21.

Where it's running

  • School of Social Sciences and Professions
    London, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: Samantha Banbury — London Metropolitan University
  • Study coordinator: Anna Kamyk
  • Email: rpo@londonmet.ac.uk
  • Phone: 02074230000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.